First Manhattan

First Manhattan’s Takeda Pharmaceutical TAK Stock Holding History

First Manhattan’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-94	Closed	-$1.3K	–	1246
2024 Q1	$1.3K	Hold	94	–	–	﹤0.01%	1323
2023 Q4	$1.34K	Sell	94 -105	-53%	-$1.49K	﹤0.01%	1313
2023 Q3	$3.08K	Buy	199 +105	+112%	+$1.63K	﹤0.01%	1281
2023 Q2	$1.48K	Hold	94	–	–	﹤0.01%	1317
2023 Q1	$1.55K	Hold	94	–	–	﹤0.01%	1397
2022 Q4	$1.47K	Hold	94	–	–	﹤0.01%	1550
2022 Q3	$1K	Hold	94	–	–	﹤0.01%	1487
2022 Q2	$1K	Hold	94	–	–	﹤0.01%	1514
2022 Q1	$1K	Hold	94	–	–	﹤0.01%	1557
2021 Q4	$1K	Hold	94	–	–	﹤0.01%	1542
2021 Q3	$1K	Buy	+94	New	+$1.58K	﹤0.01%	1562

Other funds holding TAK

Groupama Asset Management Paris, France $6.85B AUM 43.37% 1-Year Est. Return

Capital Research Global Investors

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Arrowstreet Capital

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return